ERBB2 and breast cancer: Triple-negative breast cancers (TNBCs), which do not express estrogen receptor or progesterone receptor, or overexpress HER2, are a particularly aggressive subtype of breast cancer characterized by high rates of metastases and poor prognosis [2].